Results 151 to 160 of about 200,052 (360)

Real‐World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation?

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Brian A. Bergmark
doaj   +1 more source

Feasibility and Safety of the ETcath200 Robotic PCI System for Complex Coronary Lesions: A Prospective Single‐Center Study

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background International robotic‐assisted PCI platforms such as CorPath 200 and CorPath GRX have demonstrated procedural safety and efficacy but are limited by the absence of real‐time tactile feedback and cumbersome device exchange. The ETcath200, the first domestically developed robotic PCI system in China, introduces guidewire force‐sensing
Jing Yang, Yuqi Fang, Yizhu Yan, Zijing Liu, Jing Xie, Ge Zhang, Zhicheng Zhang, Tienan Sun, Guangyao Zhai   +8 more
wiley   +1 more source

Advances in the treatment of cerebral venous sinus thrombosis

Chinese Journal of Contemporary Neurology and Neurosurgery, 2020
Cerebral venous sinus thrombosis (CVST) is a special type of stroke with an increasing rate of diagnosis and a higher rate of disability and mortality. Currently, anticoagulant therapy, systemic venous thrombolysis, arterial thrombolysis, contact venous ...
Hong-guang WANG, Yi-mu FAN
doaj  

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang, Shin‐Yi Lin, Chih‐Hao Chen, Yen‐Bin Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Jiann‐Shing Jeng   +8 more
wiley   +1 more source

Safety of thrombolysis in acute ischemic stroke patients with previous aortic abdominal aneurysm repair

Journal of Stroke and Cerebrovascular Diseases
Objective: Intravenous thrombolysis is the standard treatment for acute ischemic stroke (AIS), but its safety in patients with a history of abdominal aortic aneurysm (AAA) repair remains unclear.
Walter Duarte-Celada, MD, Katherine Rivas, MD, Pichatorn Suppakitjanusant, MD, Pamela Davila-Siliezar, MD, Myriam Vijil, MD, Ximena Gamboa, MD, Chanaka N. Kahathuduwa, MD, PhD, Riichi Ota, MD, Ross Raedeke, Darko Quispe-Orozco, MD   +9 more
doaj   +1 more source

Thrombolysis in an Ischemic Stroke Patient on Dabigatran Anticoagulation: A Case Report [PDF]

, 2012
Luiz Carlos Porcello Marrone, A. Marrone
openalex   +1 more source

Carotid Endarterectomy Following Intravenous Thrombolysis in the UK [PDF]

, 2021
Amundeep S. Johal, A. Ross Naylor, Arun Pherwani, Qiuju Li, Panagiota Birmpili, Sam Waton, Richard O’Neill, Jonathan R. Boyle, David Cromwell   +8 more
openalex   +1 more source

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Percutaneous Reperfusion Therapies vs. Anticoagulation in Patients With Acute Intermediate‐High‐Risk Pulmonary Embolism: The PRETHA Randomized Clinical Trial [PDF]

Pulm Circ
ABSTRACT The optimal treatment strategy for patients with acute intermediate–high‐risk pulmonary embolism (PE) remains uncertain. This randomized clinical trial (PRETHA) aimed to evaluate the efficacy and safety of percutaneous reperfusion therapies—trans‐catheter thrombectomy and trans‐catheter thrombolysis—compared with standard anticoagulation ...
Ivanauskienė T, Berūkštis A, Burneikaitė G, Daubaraitė A, Ivanauskaitė K, Matačiūnas M, Navickas G, Kūgienė R, Kurzyna M, Glaveckaitė S.   +9 more
europepmc   +2 more sources

Treatment of acute sub-massive pulmonary embolism with balloon angioplasty and thrombolysis simultaneously

, 2023
Mark Christopher Arokiaraj
openalex   +1 more source